Bonus Biogroup Ltd. (BBIXF)
0.13
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Bonus Biogroup Total Assets (Quarterly)
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 6.424M |
| September 30, 2024 | 7.101M |
| June 30, 2024 | 8.499M |
| March 31, 2024 | 10.60M |
| December 31, 2023 | 12.47M |
| September 30, 2023 | 13.71M |
| June 30, 2023 | 15.90M |
| March 31, 2023 | 18.48M |
| December 31, 2022 | 21.14M |
| September 30, 2022 | 22.80M |
| June 30, 2022 | 27.85M |
| March 31, 2022 | 33.14M |
| December 31, 2021 | 33.52M |
| September 30, 2021 | 36.30M |
| June 30, 2021 | 29.64M |
| March 31, 2021 | 35.48M |
| December 31, 2020 | 16.02M |
| September 30, 2020 | 11.24M |
| June 30, 2020 | 11.24M |
| March 31, 2020 | 12.21M |
| December 31, 2019 | 2.024M |
| September 30, 2019 | 2.932M |
| June 30, 2019 | 2.472M |
| Date | Value |
|---|---|
| March 31, 2019 | 3.229M |
| December 31, 2018 | 2.718M |
| September 30, 2018 | 3.097M |
| June 30, 2018 | 2.394M |
| March 31, 2018 | 1.539M |
| December 31, 2017 | 1.606M |
| September 30, 2017 | 1.267M |
| June 30, 2017 | 1.472M |
| March 31, 2017 | 1.127M |
| December 31, 2016 | 0.7525M |
| September 30, 2016 | 1.367M |
| June 30, 2016 | 1.022M |
| March 31, 2016 | 1.537M |
| December 31, 2015 | 1.479M |
| September 30, 2015 | 0.8958M |
| June 30, 2015 | 1.355M |
| March 31, 2015 | 0.9231M |
| December 31, 2014 | 1.162M |
| September 30, 2014 | 0.9741M |
| June 30, 2014 | 1.487M |
| March 31, 2014 | 2.041M |
| December 31, 2013 | 2.35M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Compugen Ltd. | 145.86M |
| Pluri, Inc. | 26.06M |
| BioLineRx Ltd. | 38.80M |
| Kamada Ltd. | 383.02M |
| Can-Fite BioPharma Ltd. | -- |